At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 157 enrolled
Drug / intervention
Simpliciti™ Shoulder Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Simpliciti IDE Trial
In Brief
A Phase 3 clinical trial evaluating Simpliciti™ Shoulder System for Primary Generalized (Osteo)Arthritis and Post-traumatic Arthrosis of Other Joints, Upper Arm. Completed, enrolled 157 participants across 14 sites.
Detailed Summary
The purpose of this study is to demonstrate safety and efficacy of the Simpliciti Shoulder System in total shoulder arthroplasty.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2011
First PostedJul 2011
Primary CompletionNov 2014
Study CompletionDec 2014
TodayJul 2026
First PostedJul 8, 2011
Enrollment StartJul 1, 2011
Primary CompletionNov 1, 2014
Study CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 15.0 years ago
Interventions
Simpliciti™ Shoulder Systemdevice
Total shoulder arthroplasty system